Multiple Sclerosis Patients With Specific Genetic Variant May Be At Higher Risk For Liver Toxicity When Treated With Interferon-Beta, Study Suggests.

Medscape (7/20, McNamara, Subscription Publication) reported researchers found that “patients with multiple sclerosis (MS) who carry a specific genetic variant identified through genome-wide testing are at significantly elevated risk for liver toxicity w...